Cytogenetic Abnormalities in Multiple Myeloma

  • Brian G. M. Durie
  • Elizabeth E. Vela
  • Valerie Baum


Cytogenic studies in multiple myeloma have been very difficult because of the predominantly low proliferative activity in this disease (1-7). In the series reported to date the most commonly affected chromosomes have been chromosomes 1 and 14: a variety of translocations and structural changes have been documented. Chromosome 14 in particular has been involved in translocations to several chromosomes, including t(11;14), t(8;14) and t (14;18). In addition to these translocations, acquisition of miscellaneous chromosomal fragments and unidentified markers (UMARS) is very frequent. Gains and losses of numerous chromosomes have also been noted. The current report summarises a preliminary analysis of a large study of 331 bone marrow specimens from 262 patients with multiple myeloma, studied at the University of Arizona.


Multiple Myeloma Cytogenetic Abnormality Myeloma Cell Line Abnormal Karyotype Plasma Cell Leukemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lewis JP, MacKenzie MR (1984): Non-random chromosomal aberrations associated with multiple myeloma. Hematol Oncol 2:307 .PubMedGoogle Scholar
  2. 2.
    DeWald GW, Kyle RA, Hicks GA, Greipp PR (1985): The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidosis. Blood 66:380 .PubMedGoogle Scholar
  3. 3.
    Kuey-Chu C, Bevan PC, Mattews JG (1986): Analysis of G banded karyotypes in myeloma cells. J Clin Pathol 39:260.CrossRefGoogle Scholar
  4. 4.
    Ranni NS, Slavutsky I, Wechsler A, Brieux S (1987): Chromosome findings in multiple myeloma. Cancer Genet Cytogenet 25:309 .PubMedCrossRefGoogle Scholar
  5. 5.
    Yamada K, Shionoya S, Amano M, Imamura Y (1983): A Burkitt-type 8;14 translocation in a case of plasma cell leukemia. Cancer Genet Cytogenet 9:67.PubMedCrossRefGoogle Scholar
  6. 6.
    Nishida K, Taniwaki M, Misawa S, Abe T, Takino T, Fujii H (1987): Translocation (14;18) found in a patient with multiple myeloma. Cancer Genet Cytogenet 25:375.PubMedCrossRefGoogle Scholar
  7. 7.
    Gould J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B (1988): Plasma cell karyotype in multiple myeloma. Blood 71:453.8.PubMedGoogle Scholar
  8. 8.
    Durie BGM, Vela E, Baum V, Leibovitz A, Payne CM, Richter LC, Grogan TM, Trent JM (1985): Establishment of two new myeloma cell lines from bilateral pleural effusions: Evidence for sequential in vivo clonal change. Blood 66:548.PubMedGoogle Scholar
  9. 9.
    Harnden GD, Jensen JT (eds) (1985): An international system for human cytogenetic nomenclature. Basel, Switzerland, S. Karges.Google Scholar
  10. 10.
    Durie BGM, Grogan TM (1985): CALLA-positive myeloma: an aggressive subtype with poor survival. Blood 66:229.PubMedGoogle Scholar
  11. 11.
    Durie BGM, Grogan TM, Spier C, Vela E, Baum V, Rodriquez MA, Frutiger Y (1989): Myelomonocytic myeloma cell line (LB 84-1). Blood 73:770.PubMedGoogle Scholar
  12. 12.
    Grogan TM, Durie BGM, Spier CM, Richter L, Vela E (1989): Myelomonocytic antigen positive multiple myeloma. Blood 73:763.PubMedGoogle Scholar
  13. 13.
    Spier C, Durie BGM, Grogan TM, Richter LC, Vela E, Frutiger Y, Rangel CS (May 1990): T cell antigen positive multiple myeloma. Mod Path, in press.Google Scholar
  14. 14.
    Neri A, Murphy JP, Cro L, Ferrero D, Tarella C, Baldini L, Dalla-Favera R (1989): RAS oncogene mutation in multiple myeloma. J Exp Med 170:1715.PubMedCrossRefGoogle Scholar
  15. 15.
    Durie B, Baum V, Vela E, Mundy G (1986): Abnormalities of chromosome 6q and osteoclast activating factor production in multiple myeloma. Blood 68:208A (abstr).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Brian G. M. Durie
    • 1
  • Elizabeth E. Vela
    • 1
  • Valerie Baum
    • 2
  1. 1.Department of Haematology, Charing Cross and Westminster Medical SchoolUniversity of London, Charing Cross HospitalLondon W6UK
  2. 2.College of MedicineThe Arizona Cancer CenterTucsonUSA

Personalised recommendations